US EditionMedivis Receives FDA 510(k) Clearance for Spine Navigation and Announces Commercial Launch in the United States
- Medivis announced the commercial launch of Spine Navigation on April 2, 2025, in New York.
- The FDA granted Medivis 510 clearance for Spine Navigation, enabling the launch.
- This platform integrates with spinal hardware and imaging systems from major vendors.
- Dr. Choudhry, CEO of Medivis, stated the technology will "visually transform spine surgery."
- Spine Navigation's FDA clearance marks a significant advancement in surgical technology available nationwide.
Insights by Ground AI
Does this summary seem wrong?
21 Articles
21 Articles
All
Left
Center
7
Right
1
Rappahannock News+18 Reposted by 18 other sources
Medivis Receives FDA 510(k) Clearance for Spine Navigation and Announces Commercial Launch in the United States
NEW YORK, April 2, 2025 /PRNewswire/ -- Medivis Inc., a pioneer in surgical intelligence, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its groundbreaking Spine Navigation platform. This milestone marks a…
Coverage Details
Total News Sources21
Leaning Left0Leaning Right1Center7Last UpdatedBias Distribution88% Center
Bias Distribution
- 88% of the sources are Center
88% Center
C 88%
13%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
